Cargando…
Current state and future evolution of pancreatic islet transplantation
Pancreatic islet transplantation provides an effective treatment option for patients with type 1 diabetes (T1D) with intractable impaired awareness of hypoglycemia and severe hypoglycemic events. Currently, the primary goal of islet transplantation should be excellent glycemic control without severe...
Autores principales: | Anazawa, Takayuki, Okajima, Hideaki, Masui, Toshihiko, Uemoto, Shinji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345654/ https://www.ncbi.nlm.nih.gov/pubmed/30697608 http://dx.doi.org/10.1002/ags3.12214 |
Ejemplares similares
-
Mitomycin C treatment improves pancreatic islet graft longevity in intraportal islet transplantation by suppressing proinflammatory response
por: Yamane, Kei, et al.
Publicado: (2020) -
The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation
por: Tada, Seiichiro, et al.
Publicado: (2020) -
Long‐term outcome of islet transplantation on insulin‐dependent diabetes mellitus: An observational cohort study
por: Nakamura, Toshihiro, et al.
Publicado: (2019) -
Reduced glycemic variability and flexible graft function after islet transplantation: A case report
por: Nakamura, Toshihiro, et al.
Publicado: (2020) -
Long-term Prognosis and Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: A Single-Center Experience
por: Ueda, Yoshihide, et al.
Publicado: (2017)